Published 2022 | Version v1
Journal article

Predicting death or recurrence of portal hypertension symptoms after TIPS procedures

  • 1. Department of Radiology, New York Presbyterian Hospital, New York, NY (United States)
  • 2. Department of Radiology, Columbia University Vagellos College of Physicians and Surgeons, 10032, New York, NY (United States)
  • 3. Radiology Department, Rangueil University Hospital, 1, avenue du Professeur Jean Poulhes, 31059, Toulouse (France)
  • 4. Hepato-Gastroenterology Department, Purpan University Hospital, Toulouse (France)
  • 5. The Digestive Surgery and Liver Transplantation Department, Toulouse University Hospital, Toulouse (France)

Description

Accurate prediction of portal hypertension recurrence after transjugular intrahepatic portosystemic shunt (TIPS) placement will improve clinical decision-making. To evaluate if perioperative variables could predict disease-free survival (DFS) in cirrhotic patients with portal hypertension (PHT) treated with TIPS. We recruited 206 cirrhotic patients with PHT treated with TIPS, randomly assigned to training (n = 138) and validation (n = 68) sets. We recorded 7 epidemiological, 4 clinical, and 9 radiological variables. TIPS-distal end positioning (TIPS-DEP) measured the distance between the distal end of the stent and the hepatocaval junction on contrast-enhanced CT scans. In the training set, the signature was defined as the random forest for survival algorithm achieving the lowest error rate for the prediction of DFS which was landmarked 4 weeks after the TIPS procedure. In the training set, a simple to use scoring system was derived from variables selected by the signature. The primary endpoint was to assess if TIPS-DEP was associated with DFS. The secondary endpoint was to validate the scoring system in the validation set. Overall, patients with TIPS-DEP ≥ 6 mm (n = 49) had a median DFS of 24.5 months vs. 72.8 months otherwise (n = 157, p = 0.004). In the training set, the scoring system was calculated by adding age ≥ 60 years old, Child-Pugh B or C, and TIPS-DEP ≥ 6 mm (1 point each) since the signature showed high DFS probability at 6.5 months post-landmark in patients that did not meet these criteria: 86%, 80%, and 78%, respectively. The hazard ratio [95 CI] between patients determined to be low-risk (< 2 points) and high-risk (≥ 2 points) was 2.30 [1.35-3.93] (p = 0.002) in the training set and 2.01 [0.94-4.32] (p = 0.072) in the validation set. TIPS-DEP is an actionable radiological biomarker which can be combined with age and Child-Pugh score to predict death or PHT symptom recurrence after TIPS procedure. TIPS-DEP measurement was the third most important but only actionable variable for predicting DFS. TIPS-DEP < 6 mm was associated with a DFS probability of 78% at 6.5 months post-landmark. A simple scoring system calculated using age, Child-Pugh score, and TIPS-DEP predicted DFS after TIPS.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-021-08437-0

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology (Internet)
Journal Volume
32
Journal Issue
5
Journal Page Range
p. 3346-3357
ISSN
1432-1084
CODEN
EURAE3